“…GH treatment promotes a state of intrahepatic triglyceride storage. Several studies in bGHtransgenic mice, defficient GHR-JAK2-STAT-5 signaling pathway, GH-treated intact or GHdeficient rats (hypophysectomized or hypothyroid), as well as experiments in PPAR null mice, have all revealed that GH down-regulates genes involved in lipid oxidation and increases the expression of genes promoting lipogenesis in the liver (Olsson et al, 2003;Wang et al, 2007;Barclay et al, 2011;Sos et al, 2011). On the other hand, an impaired GHR-JAK2-STAT-5 signaling strongly correlates with hepatic steatosis (Fan et al, 2009;Barclay et al, 2011;Sos et al, 2011).…”